These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 23110068)

  • 1. Hepatitis C virus phylogenetic clustering is associated with the social-injecting network in a cohort of people who inject drugs.
    Sacks-Davis R; Daraganova G; Aitken C; Higgs P; Tracy L; Bowden S; Jenkinson R; Rolls D; Pattison P; Robins G; Grebely J; Barry A; Hellard M
    PLoS One; 2012; 7(10):e47335. PubMed ID: 23110068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A latent class approach to identify multi-risk profiles associated with phylogenetic clustering of recent hepatitis C virus infection in Australia and New Zealand from 2004 to 2015.
    Bartlett SR; Applegate TL; Jacka BP; Martinello M; Lamoury FM; Danta M; Bradshaw D; Shaw D; Lloyd AR; Hellard M; Dore GJ; Matthews GV; Grebely J
    J Int AIDS Soc; 2019 Feb; 22(2):e25222. PubMed ID: 30746864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV infection and hepatitis C virus genotype 1a are associated with phylogenetic clustering among people with recently acquired hepatitis C virus infection.
    Bartlett SR; Jacka B; Bull RA; Luciani F; Matthews GV; Lamoury FM; Hellard ME; Hajarizadeh B; Teutsch S; White B; Maher L; Dore GJ; Lloyd AR; Grebely J; Applegate TL
    Infect Genet Evol; 2016 Jan; 37():252-8. PubMed ID: 26631810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of direct and indirect social and spatial ties in the diffusion of HIV and HCV among people who inject drugs: a cross-sectional community-based network analysis in New Delhi, India.
    Clipman SJ; Mehta SH; Srikrishnan AK; Zook KJ; Duggal P; Mohapatra S; Shanmugam S; Nandagopal P; Kumar MS; Ogburn E; Lucas GM; Latkin CA; Solomon SS
    Elife; 2021 Aug; 10():. PubMed ID: 34342266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug use and phylogenetic clustering of hepatitis C virus infection among people who use drugs in Vancouver, Canada: A latent class analysis approach.
    Jacka B; Bray BC; Applegate TL; Marshall BDL; Lima VD; Hayashi K; DeBeck K; Raghwani J; Harrigan PR; Krajden M; Montaner JSG; Grebely J
    J Viral Hepat; 2018 Jan; 25(1):28-36. PubMed ID: 28719060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methamphetamine injecting is associated with phylogenetic clustering of hepatitis C virus infection among street-involved youth in Vancouver, Canada.
    Cunningham EB; Jacka B; DeBeck K; Applegate TL; Harrigan PR; Krajden M; Marshall BD; Montaner J; Lima VD; Olmstead AD; Milloy MJ; Wood E; Grebely J
    Drug Alcohol Depend; 2015 Jul; 152():272-6. PubMed ID: 25977204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlates of hepatitis C viral clustering among people who inject drugs in Baltimore.
    Hackman J; Falade-Nwulia O; Patel EU; Mehta SH; Kirk GD; Astemborski J; Ray SC; Thomas DL; Laeyendecker O
    Infect Genet Evol; 2020 Jan; 77():104078. PubMed ID: 31669367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors associated with phylogenetic clustering of hepatitis C among people who inject drugs in Baltimore.
    Falade-Nwulia O; Hackman J; Mehta SH; McCormick SD; Kirk GD; Sulkowski M; Thomas D; Latkin C; Laeyendecker O; Ray SC
    BMC Infect Dis; 2020 Nov; 20(1):815. PubMed ID: 33167892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phylogenetic analysis of full-length, early infection, hepatitis C virus genomes among people with intravenous drug use: the InC
    Rodrigo C; Eltahla AA; Bull RA; Luciani F; Grebely J; Dore GJ; Applegate T; Page K; Bruneau J; Morris MD; Cox AL; Osburn W; Kim AY; Shoukry NH; Lauer GM; Maher L; Schinkel J; Prins M; Hellard M; Lloyd AR;
    J Viral Hepat; 2017 Jan; 24(1):43-52. PubMed ID: 27808453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phylogenetic clustering of hepatitis C virus among people who inject drugs in Vancouver, Canada.
    Jacka B; Applegate T; Krajden M; Olmstead A; Harrigan PR; Marshall B; DeBeck K; Milloy MJ; Lamoury F; Pybus OG; Lima VD; Magiorkinis G; Montoya V; Montaner J; Joy J; Woods C; Dobrer S; Dore GJ; Poon AF; Grebely J
    Hepatology; 2014 Nov; 60(5):1571-1580. PubMed ID: 25042607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of response-guided directly observed pegylated interferon and self-administered ribavirin for people who inject drugs with hepatitis C virus genotype 2/3 infection: The ACTIVATE study.
    Grebely J; Dalgard O; Cunningham EB; Hajarizadeh B; Foster GR; Bruggmann P; Conway B; Backmund M; Robaeys G; Swan T; Amin J; Marks PS; Quiene S; Applegate TL; Weltman M; Shaw D; Dunlop A; Hellard M; Bruneau J; Midgard H; Bourgeois S; Staehelin C; Dore GJ;
    Int J Drug Policy; 2017 Sep; 47():177-186. PubMed ID: 28624134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short and sporadic injecting cessation episodes as predictors of incident hepatitis C virus infection: findings from a cohort study of people who inject drugs in Montréal, Canada.
    Fortier E; Artenie AA; Zang G; Jutras-Aswad D; Roy É; Grebely J; Bruneau J
    Addiction; 2019 Aug; 114(8):1495-1503. PubMed ID: 30957310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Change in hepatitis C virus genotype in injecting drug users.
    Aitken C; McCaw R; Jardine D; Bowden S; Higgs P; Nguyen O; Crofts N; Hellard M
    J Med Virol; 2004 Dec; 74(4):543-5. PubMed ID: 15484265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular epidemiology of hepatitis C virus in a social network of injection drug users.
    Aitken CK; McCaw RF; Bowden DS; Tracy SL; Kelsall JG; Higgs PG; Kerger MJ; Nguyen H; Crofts JN
    J Infect Dis; 2004 Nov; 190(9):1586-95. PubMed ID: 15478062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of Acute HCV Infection and Transmission Networks in People Who Currently Inject Drugs in Catalonia: Usefulness of Dried Blood Spots.
    Antuori A; Montoya V; Piñeyro D; Sumoy L; Joy J; Krajden M; González-Gómez S; Folch C; Casabona J; Matas L; Colom J; Saludes V; Martró E;
    Hepatology; 2021 Aug; 74(2):591-606. PubMed ID: 33609288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Never injected, but hepatitis C virus-infected: a study among self-declared never-injecting drug users from the Amsterdam Cohort Studies.
    van den Berg CH; van de Laar TJ; Kok A; Zuure FR; Coutinho RA; Prins M
    J Viral Hepat; 2009 Aug; 16(8):568-77. PubMed ID: 19243497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploratory social network analysis and gene sequencing in people who inject drugs infected with hepatitis C virus.
    Wang Y; Tan XD; Zhou C; Zhou W; Peng JS; Ren YS; Ni ZL; Liu B; Yang F; Gao XD
    Epidemiol Infect; 2016 Oct; 144(14):3080-3090. PubMed ID: 27405277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis C transmission and treatment as prevention - The role of the injecting network.
    Hellard M; McBryde E; Sacks Davis R; Rolls DA; Higgs P; Aitken C; Thompson A; Doyle J; Pattison P; Robins G
    Int J Drug Policy; 2015 Oct; 26(10):958-62. PubMed ID: 26072105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transmission of hepatitis C virus infection among younger and older people who inject drugs in Vancouver, Canada.
    Jacka B; Applegate T; Poon AF; Raghwani J; Harrigan PR; DeBeck K; Milloy MJ; Krajden M; Olmstead A; Joy JB; Marshall BD; Hayashi K; Pybus OG; Lima VD; Magiorkinis G; Montaner J; Lamoury F; Dore GJ; Wood E; Grebely J
    J Hepatol; 2016 Jun; 64(6):1247-55. PubMed ID: 26924451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spatiotemporal Phylodynamics of Hepatitis C Among People Who Inject Drugs in India.
    Clipman SJ; Mehta SH; Rodgers MA; Duggal P; Srikrishnan AK; Saravanan S; Balakrishnan P; Vasudevan CK; Ray SC; Kumar MS; Quinn TC; Cloherty GA; Lucas GM; Solomon SS
    Hepatology; 2021 Oct; 74(4):1782-1794. PubMed ID: 34008172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.